Epigenetic alterations in the multifaceted inhibitory effects of metformin on castration resistant prostate cancer

被引：1
|
作者：
Li, Xin [1 ]
Wei, Juncheng [1 ]
Matsumura, Satoko [1 ]
Guo, Yuqi [1 ]
Yuan, Huawei [1 ]
机构：
[1] NYU, New York, NY USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Relationship between epigenetic and metabolic alterations in castration-resistant prostate cancer
    Kanesaka, Manato
    Sato, Hiroaki
    Hoshii, Takayuki
    Okabe, Atsushi
    Fukuyo, Masaki
    Nawai, Bahityar R.
    Sakamoto, Shinichi
    Komiya, Akira
    Ichikawa, Tomohiko
    Kaneda, Atsushi
    CANCER SCIENCE, 2022, 113 : 1592 - 1592
  • [2] Alterations in response to hypoxia in gaining castration resistant prostate cancer
    Kanesaka, Manato
    Sato, Hiroaki
    Sugiura, Masahiro
    Hoshii, Takayuki
    Okabe, Atsushi
    Fukuyo, Masaki
    Sakamoto, Shinichi
    Komiya, Akira
    Ichikawa, Tomohiko
    Kaneda, Atsushi
    CANCER SCIENCE, 2021, 112 : 512 - 512
  • [3] Molecular alterations and emerging targets in castration resistant prostate cancer
    Lorente, D.
    De Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 753 - 764
  • [4] Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
    Spratt, Daniel E.
    Zhang, Chi
    Zumsteg, Zachary S.
    Pei, Xin
    Zhang, Zhigang
    Zelefsky, Michael J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 709 - 716
  • [5] Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer
    Simpson, Kendall
    Allison, Derek B.
    He, Daheng
    Liu, Jinpeng
    Wang, Chi
    Liu, Xiaoqi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (01):
  • [6] Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
    Nickerson, Michael L.
    Im, Kate M.
    Misner, Kevin J.
    Tan, Wei
    Lou, Hong
    Gold, Bert
    Wells, David W.
    Bravo, Hector C.
    Fredrikson, Karin M.
    Harkins, Timothy T.
    Milos, Patrice
    Zbar, Berton
    Linehan, W. Marston
    Yeager, Meredith
    Andresson, Thorkell
    Dean, Michael
    Bova, G. Steven
    HUMAN MUTATION, 2013, 34 (09) : 1231 - 1241
  • [7] SIMVASTATIN AND METFORMIN: A DEADLY COMBINATION FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Babcook, Melissa
    Shukla, Sanjeev
    Sramkoski, Michael
    Fu, Pingfu
    Vazquez, Edwin
    Puchowicz, Michelle
    Oak, Christine
    Molter, Joseph
    MacLennan, Gregory
    Flask, Chris
    Lindner, Daniel
    Parker, Yvonne
    Gupta, Sanjay
    JOURNAL OF UROLOGY, 2014, 191 (04): : E766 - E766
  • [8] Metformin enhances the efficacy of enzalutamide treatment in castration-resistant prostate cancer
    Simpson, Kendall Elizabeth
    Zhang, ZhuangZhuang
    Zhang, Qiongsi
    Liu, Xiaoqi
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Developing a multifaceted approach to target androgen receptor (AR) in castration resistant prostate cancer
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Tapadar, Subhasish
    Wu, Bocheng
    Adegboyega, Oyelere
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Epigenetic modifications of androgen receptor signaling in castration resistant prostate cancer (CRPC)
    Sarac, H.
    Toparlak, O. D.
    Kaplan, A.
    Ebrahimi, A.
    Bagci-Onder, T.
    Onder, T.
    Lack, N. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S99 - S99
12345